X-Health.show

The surgeons received the collagen-based mesh the day before and were ready to reconstruct urethra with it. How come? “We have done a first-in-man study involving five urethra stricture patients,” Eva-Maria Balet, the CEO of Regenosca SA recalls on the new X-Health.show. “And it was a very emotional moment to give the first TissueSpan meshes to a surgeon in the surgery room. He used it in the gold standard treatment, though, that means he removed the scarred portion of the urethra, and then, instead of taking the inner mouth tissue from the patient, he simply took our TissueSpan mesh.” Regenosca is a Swiss startup developing TissueSpan mesh – a technology platform to create regenerative, off-the-shelf meshes for soft tissue repair. Their first indication is urethral stricture – first-in-human implantations show shorter surgery time and less pain for patients. In this episode, you will hear about 🎧 urethral stricture 🎧 regenerative medicine 🎧 what did the surgeon say after the first surgery 🎧 a collagen-based scaffold that attracts a patient’s own cells surrounding the removed tissue and stimulates regeneration Also, listen to how it dissolves leaving a healthy tissue behind on Apple Podcasts Spotify or wherever you listen to your podcasts and look for X-Health show #regeneratievmedicine #healthcareinnovation #futureofhealthcare #futureofhealth #swissstartups #xhealth 

She’s there to support the traditional watch industry in the IoT world. In the world where Apple Watches sell more and more and traditional watches sell less and less… “…they are aware that a big part of the watch industry can really die from this competition”, Olga Nijpels-Tishurova, the CEO of Watchibia said on the new X-Health.show episode. “But the competition is not fair, because they are competing the tradition against technology.” It’s not a traditional competitor. The old rules of engagement don’t apply. “I love the mechanics, I love the craftsmanship so much I want to give them, to provide them a tool with which they can actually compete on a different level. So I really want to see the watch industry rise and shine. That's why I chose the B2B segment and B2B2C. I'm fine to stay in the background, just to let them to give them a tool to get back on the point where they were before.” By adding a smart health tracking strap to a Rolex. Or Omega. Or Patek Philippe – whatever watch you fancy. Watchibia is a Swiss startup that is developing a smart strap for traditional watches with collaboration with CSEM. No additional fitness tracker needed. In this episode, you will hear about ⌚ a health tracker that matches your style ⌚ high-end vulcanized rubber ⌚ what you can track with a smart strap ⌚ and how a smart strap can save the traditional watch industry Listen on 🎧 Apple Podcasts Spotify or wherever you listen to your podcasts and look for X-Health show Sitem StartUp Club (SSC) it was awesome to record at your place – thank you 🙏 #luxurywatches #luxurybrands #wearables #healthtech #smartwatch #swissstartups #xhealth

How large is this device? Have a look at its capabilities and give it a guess: "On the one hand, it can provide specific separation of extracellular vesicles according to subpopulation and on the other hand, it allows high throughput. And it separates extracellular vesicles in less than 10 minutes" Adva Krivitsky, a co-founder and CEO of Acytronix, described their device on the new X-Health.show episode. I watched the video of the process. And it was even quicker than 10 minutes. That fast, right? Add high purity to the mix and you’ll realise just how groundbreaking it is. In this new episode, we’re talking about nanomedicine, the medicine of the future, where extracellular vesicles are used in both diagnostics and as therapeutics. For cancer, diabetes, and many other diseases. So, did you guess the size of the device? If you thought you could hold it in your hand, you were spot on. Now, you’ve also realised, it could be, in the future, used at doctor’s offices. Listen to how that’s possible 🎧 on Apple Podcasts 🎧 or Spotify 🎧 or wherever you listen to your podcasts – look for X-Health show Acytronix is a Swiss startup that developed a portable microstructured electrochemical device to isolate extracellular vesicles in less than 10 minutes. These extracellular vesicles can be key in detecting and treating diseases–more gently–in the future. Their device is already available for research. #nanomedicine #medicalinnovation #futureofhealthcare #healthcareinnovation #cancer #swissstartups #digitalhealth #xhealth

Do you know what your screen time is? And how much does it cost? “Our attention is the resource that these companies are harvesting and then selling to the highest bidder,” emphasised Ondrej Zak, the CEO of Zario on the new X-Health.show episode. We are selling our time. And what Zario does is fighting fire with fire. “We tried many different things, but we realized that what helps the best is to use the same methods social media uses to get us hooked, to get us unhooked. So we’re deploying some of the mechanisms in different parts of the app, and we realized that, yeah, this is what is the most efficient at reducing screen time in the long term.” In this episode, you’ll hear about 📱 a phone addiction – or “problematic phone use” if you prefer 📱 how to tell if you’re addicted to your phone 📱 how to break that habit 📱 and how an app can help Also, listen to how to check your screen time on your phone on Apple Podcasts or Spotify or wherever you listen to your podcasts – look for X-Health show #mentalwellbeing #screentime #phone #addiction #app #swissstartups #digitalhealth #xhealth

One co-founder, Willy Bischofberger lost 40 kg of weight himself. The medical advisor, Stefan Zechmann, needed support to help his patients lose weight for good. With no magic diet. “We have three pillars. So we have the app that is our entry point. It's a web app. It's also a mobile app, as you want, it's the entry point to access several things,” Julia Vogel Wenzin, the other co-founder and CEO of LEALY, said on the new X-Health.show episode. So there's: 👥👥 community of people with BMI above 25 👥👥 coaching groups 👥👥 25 course modules: videos, videos plus quizzes, that each explain one aspect of changing habits “And we talk about sleep as much as we talk about reflux and we talk about nutrition as much as we do about which products can you buy at the local Migros shop.” Already available in Switzerland. As the number of participants grows, the AI will come on-board. And scaling to other countries will follow. LEALY is a Swiss startup that helps overweight people lose weight. Not by offering any miraculous diet. With the origins at a Swiss private clinic, they now offer in their app a blended care habit change program. In this episode you will hear about 🎧 4 simple rules you will want to follow to lose weight 🎧 why most people would NOT follow them 🎧 how one of the co-founders lost 40 kilos 🎧 and how LEALY achieved an 80% success rate Have a listen on Apple Podcasts Spotify or wherever you listen to your podcasts and look for X-Health show #weightloss #obesity #healthcareinnovation #futureofhealthcare #futureofhealth #swissstartups #xhealth

By 2030, around 1% of the global meat market could be covered by cultivated meat. Meat made from cells. Cultured meat. “Obviously, if it grows faster, I think everyone in the ecosystem is happy,” Nicole Kleger, the CTO of sallea said on the new X-Health.show episode. We’re speaking about 1% of around $30B. Is it more about technical challenges or cultural? Aleksandra Jani asks. “It’s absolutely both. On the technical side, the ecosystem could already show that it is possible to grow cells and to create a piece of meat that tastes [good], that we can reach the hygiene standards and the safety standards that it's safe to eat. Now, the whole ecosystem is in a transformation toward scaling up, so to create the volumes that are needed to create a food product and at the price, which is relevant for the market. At the same time, there is a lot of political discussions going on, if cultivated meat should be allowed on the market, how it should be regulated, what kind of legal standards need to be fulfilled, that we can enter the market.” In this episode, you’ll hear about 🥩 what is cultivated meat? 🥩 why it’s called lab meat and beer isn’t? 🥩 how meat is cultivated from cells 🥩 does it taste like meat 🥩 how healthy is it and much more sallea is a Swiss startup, an ETH Zurich spin-off, developing edible scaffolds to grow cultivated meat. Their scaffolds, which enable cells to grow into meat, promise your taste buds real meat experience – without sacrificing animals. Head to Apple Podcasts https://rebrand.ly/lmylvrd Spotify https://rebrand.ly/u9o1zht or wherever you listen to your podcasts and look for the X-Health show #cultivatedmeat #alternativeprotein #alternativeproteins #foodinnovation #foodscience #swissstartups #xhealth ETH Entrepreneurship startup days

He’s genetically tested professional athletes and also, extensively, himself and his identical twin brother. We’re speaking about multiomics in this episode, with a focus on genomics 🧬 And sports. I couldn’t help but ask, what if they tested an athlete and the results indicated, she or he is not particularly gifted in the discipline they compete in. “In fact, my identical twin brother and I are a good case study for that,” Thomas Roos, a sports genetics and genetic epidemiology scientist, entrepreneur, a retired professional triathlete recalls on the new X-Health.show episode. “If a coach was to see me when I was a kid, and if a scientist was to see my biological data, there would be zero prediction that I would have become an athlete”. Based on population-wide genomic studies, he gives a pretty precise % of how much genes contribute towards becoming an elite-level athlete – the world championship or Olympic level. We’re speaking at AISTS, the International Academy of Sports Science and Technology, in the Synathlon building at the University of Lausanne. But he has recently joined 5 Ironman’s to Beat Alzheimer’s, an initiative we’ve already featured on the podcast, to conduct a longitudinal study on how lifestyle can push back dementia. So, you will hear about 🏃🏿♀️sports genomics 🏊🏼♂️genetic-based training 🚴🏽genetic tests to predict injuries in athletes and more Head to 🎙️Apple Podcasts https://rebrand.ly/acofwa2 🎧Spotify https://rebrand.ly/ly0prcc or wherever you listen to your podcasts and look for X-Health show #genomics #sportsperformance #healthinnovation #futureofhealth #swissstartups #xhealth BioAlps - Swiss Health Valley AISTS (International Academy of Sport Science and Technology)

One of my posts turned out to be kind of prophetic 😉 But let me start with huge congratulations: HAYA Therapeutics has just signed a $1 billion multi-year collaboration with Eli Lilly and Company 👏🏽 👏🏽 👏🏽 “This year is a very important year for HAYA,” Samir Ounzain, said on X-Health.show podcast 3 months ago. “Over the next few months, we are looking to raise our next financing round that will allow us to take our lead program into patients into clinical development, as well as continue building the pipeline and the platform.” HAYA Therapeutics is developing a platform to develop highly targeted drugs to address many diseases. As a result of Samir’s over 15 years of research into the dark genome 🧬, he discovered hundreds of long non-coding RNAs. One of them, called Wisper, has been selected to address 🫀 cardiovascular disease. A bit further down their pipeline:  🫁 lung fibrosis,  🦠 the cancer microenvironment,  💊 liver, pancreas, and kidney. “But we ultimately are a relatively small company with limited resources,” continued Samir on the podcast. "So we absolutely would love to find ways to partner with larger organizations to provide them with our know-how in mining the dark genome and for them to potentially discover new medicines in many different diseases.” And 💥 the collab signed 3 months later to target obesity and related metabolic conditions. 🙌 Sam and the team If you still haven’t listened to the episode, I couldn't recommend it more as Samir has this wonderful ability to explain complex ideas such as 🧬 dark genome 👉 long non-coding RNAs 👉 and how the dark genome may have the answer to many, many diseases on Apple Podcasts https://rebrand.ly/e1wcxdu or on Spotify https://rebrand.ly/6acfff And the “prophetic” post? Have a look at a screenshot of my LinkedIn Featured highlight in the comments 😉 👇🏽

An open wound causes trouble even after a successful Ventricular Assist Device 🫀implantation because a cable, a medical grade cable, isn’t good enough for the skin to heal properly. An end-stage heart failure patient’s life is saved 🫀 but there may be re-admissions to the hospital because of infections caused by the wound in the abdomen where the cable, connecting the implanted device that is helping the heart to pump blood goes through the skin. And in some cases, this wound simply won’t heal. “The first priority is to improve patient experience when they receive such a challenging life saving therapy,” Andreas Kourouklis, the CEO of COSKIN devices says on the new X-Health.show episode. “So in a way, we minimize the concern for very meticulous and regular wound management from the patients’ side, and then eventually, by preventing infection, means that the patients will have much faster recovery after they're operated.” 🟰 fewer days in hospital 🟰 clinical staff able to care for other patients 🟰 preventing infections 🟰 opening VAD implants to more patients COSKIN is a Swiss startup, an ETH spin-off, that develops a biocompatible medical cable to support end-stage heart failure patients. Unlike today’s cables powering mechanical circulatory support systems such as VADs, it resembles human tissue and prevents infections. In this X-Health show episode you will hear about: 🫀what options are there for an end-stage heart failure patient 🫀what is VAD 🫀how a wound heals – from a mechanical perspective 🫀what are mechanical and biological properties of skin 🫀and what makes a skin-friendly, or biocompatible, cable Listen on Apple Podcasts https://rebrand.ly/siqgx05 Spotify https://rebrand.ly/fihczg2 or wherever you listen to your podcasts and look for X-Health show #cardiology #heartfailure #VAD #healthcareinnovation #futureofhealthcare #futureofhealth #swissstartups #xhealth startup days ETH Entrepreneurship

Put the VR headset on and follow the instructions: “Think about something which stresses you and then when you visualize this, you see, ah, the pupil reacts,” Marc Bächinger, the co-inventor of myflow by MindMetrix AG and the CEO of the startup said on the new X-Health.show episode. “Then I tell you, okay, and now think of something which relaxes you. Think of a quiet day at the beach with your family. It's a nice day. And then you see your pupil size decreases. It's a bit more complex than that, but in the end, we give live feedback and you learn mental strategies, visualization strategies, to actually control your pupil”. But why would you want to control the size of your pupil? Because the feedback reflects changes deep in your brain stem, in the locus coeruleus. And if you can train your locus coeruleus, a nucleus involved in responses to stress, you can control your arousal level: stay calm, for example. myflow is a Virtual Reality application that allows professional athletes to track, analyze, and optimize their mental training by measuring the size of their pupils. You will hear 🧠 why professional athletes need mental training 🧠 what flow is 🧠 how your pupil size changes when you are relaxed or aroused And if you’re curious, 👁 how to control your mind by controlling your pupil, go to Apple Podcasts https://rebrand.ly/zfppuwg or Spotify https://rebrand.ly/2gjosno or wherever you listen to your podcasts and look for X-Health show. #VR #mentalhealth #mentaltraining #mentalcoach #futureofhealth #swissstartups #xhealth ETH Entrepreneurship startup days